This company has been acquired
QTVL.F Stock Overview
Quantum Healthcare Limited, together with its subsidiaries, engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases in Singapore.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Quantum Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.0025 |
| 52 Week High | S$0.0072 |
| 52 Week Low | S$0.0022 |
| Beta | 1.53 |
| 1 Month Change | 0% |
| 3 Month Change | -16.67% |
| 1 Year Change | -37.50% |
| 3 Year Change | -37.50% |
| 5 Year Change | -87.50% |
| Change since IPO | -99.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| QTVL.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -1.4% | -0.7% |
| 1Y | -37.5% | 7.4% | 25.9% |
Return vs Industry: QTVL.F underperformed the US Medical Equipment industry which returned -24.2% over the past year.
Return vs Market: QTVL.F underperformed the US Market which returned -12.7% over the past year.
Price Volatility
| QTVL.F volatility | |
|---|---|
| QTVL.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: QTVL.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine QTVL.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Thomas Tan | https://quantumhealthcare.com.sg |
Quantum Healthcare Limited, together with its subsidiaries, engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The company provides coronary products, including Chocolate percutaneous transluminal coronary angioplasty (PTCA) balloon catheter to reduce vessel trauma by providing balloon inflation; and Glider PTCA balloon catheter for the treatment of various complex lesions. It also offers Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for atraumatic dilatation in the treatment of blocked arteries; Chocolate Touch PTA balloon catheter to treat peripheral vascular disease; GliderfleX PTA balloon catheter for treating distal peripheral vessels; and GliderXtreme PTA balloon catheter that targets complex lesions in the distal peripheral vasculature.
Quantum Healthcare Limited Fundamentals Summary
| QTVL.F fundamental statistics | |
|---|---|
| Market cap | US$20.03m |
| Earnings (TTM) | -US$3.91m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-5.2x
P/E RatioIs QTVL.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QTVL.F income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$3.91m |
| Earnings | -US$3.91m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00055 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -18.7% |
How did QTVL.F perform over the long term?
See historical performance and comparison